Filament Health Corp. (FLHLF) は上場企業です ヘルスケア セクターの Drug Manufacturers - Specialty & Generic 業界で事業展開. 本社所在地は Burnaby, BC, カナダ. 現CEOは Benjamin Lightburn.
FLHLF を有する IPO日 2021-09-03, 13 名の正社員, に上場 Other OTC, 時価総額 $26.18K.
Filament Health Corp. operates as a natural psychedelic drug discovery and extraction technology company. It propagates psychedelic plants; conducts genetic research; performs extraction procedures; runs in-house trials; and distributes IP and drug candidates to drug developers, researchers, and other licensed parties. The company is headquartered in Vancouver, Canada.
